Olux

Olux is a brand name of clobetasol topical, approved by the FDA in the following formulation(s):

OLUX (clobetasol propionate - aerosol, foam; topical)

• 
  Manufacturer: STIEFEL LABS INC
  
  Approval date: May 26, 2000
  
  Strength(s): 0.05% ^[RLD][AB]

Has a generic version of Olux been approved?

A generic version of Olux has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Olux and have been approved by the FDA:

clobetasol propionate aerosol, foam; topical

• 
  Manufacturer: PERRIGO ISRAEL
  
  Approval date: March 10, 2008
  
  Strength(s): 0.05% ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Olux. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition
  Patent 6,126,920
  Issued: October 3, 2000
  Inventor(s): Jones; Julie Irene & Baker; Anthony Richard & Halls; Neil Graham & Watmough; Peter & Marriott; Peter
  Assignee(s): Medeva Europe PLC
  Methods of treating various skin diseases, and in particular, scalp psoriasis, utilizing a foamable pharmaceutical composition comprising a corticosteroid active substance, a quick-break foaming agent, a propellant and a buffering agent are disclosed. The quick-break foaming agent typically comprises an aliphatic alcohol, water, a fatty alcohol and a surface active agent.
  
  Patent expiration dates:
  
  
  • March 1, 2016
    
    ✓ 
    Patent use: METHOD OF TREATING A SKIN DISEASE WITH A CORTICOSTEROID-CONTAINING PHARMACEUTICAL COMPOSITION
  
  

See also...

• Olux Foam Consumer Information (Wolters Kluwer)
• Olux Consumer Information (Cerner Multum)
• Olux Advanced Consumer Information (Micromedex)
• Clobetasol Cream Consumer Information (Wolters Kluwer)
• Clobetasol Emollient Foam Consumer Information (Wolters Kluwer)
• Clobetasol Foam Consumer Information (Wolters Kluwer)
• Clobetasol Gel Consumer Information (Wolters Kluwer)
• Clobetasol Lotion Consumer Information (Wolters Kluwer)
• Clobetasol Shampoo Consumer Information (Wolters Kluwer)
• Clobetasol Solution Consumer Information (Wolters Kluwer)
• Clobetasol Spray Consumer Information (Wolters Kluwer)
• Clobetasol topical Consumer Information (Cerner Multum)
• Clobetasol Propionate Advanced Consumer Information (Micromedex)
• Med Clobetasol Scalp Application Advanced Consumer Information (Micromedex)
• Ratio-Clobetasol Advanced Consumer Information (Micromedex)
• Clobetasol Topical application Advanced Consumer Information (Micromedex)
• Clobetasol Propionate AHFS DI Monographs (ASHP)